Evidence map›Paper›PMID 37234706›Full record

ArticleFrontiers in pharmacology2023

Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data.

Luciana Bertholim-Nasciben, Marilia O Scliar, Guilherme Debortoli, Bhooma Thiruvahindrapuram, Stephen W Scherer, Yeda A O Duarte, Mayana Zatz, Guilherme Suarez-Kurtz, Esteban J Parra, Michel S Naslavsky

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. A systematic review of real-world evidence on the clinical relevance, characterization, and utility ofJournal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Luciana Bertholim-NascibenSchool of Public Health, University of São Paulo, São Paulo, Brazil.
Marilia O ScliarHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, Brazil.
Guilherme DebortoliDepartment of Anthropology, University of Toronto at Mississauga, Mississauga, ON, Canada.
Bhooma ThiruvahindrapuramThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada.
Stephen W SchererThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada.
Yeda A O DuarteMedical-Surgical Nursing Department, School of Nursing, University of São Paulo, São Paulo, Brazil.
Mayana ZatzHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, Brazil.
Guilherme Suarez-KurtzDivisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
Esteban J ParraDepartment of Anthropology, University of Toronto at Mississauga, Mississauga, ON, Canada.
Michel S NaslavskyHuman Genome and Stem Cell Research Center, University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

admixtureCPIC guidelinespharmacogenomicsPharmGKBpopulation cohortwhole-genome sequencing

Identifiers

PMID37234706
PMCPMC10206227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.